InsiderClue
Insiders · Profile

KURIYEL RALF

Senior VP, R&D at REPLIGEN. Filing since 18 Dec 2018. CIK 0001733143

Company
Date
Role
Action
Shares
Amount
Of holding
RGEN REPLIGEN CORP
2 Aug 2024
Senior VP, R&D
Sold at will
7,148
$1.14M
36.8%
RGEN REPLIGEN CORP
1 Aug 2024
Senior VP, R&D
Sold at will
4,465
$739.72K
18.8%
RGEN REPLIGEN CORP
11 Mar 2024
Senior VP, R&D
Sold at will
3,517
$681.35K
12.7%
RGEN REPLIGEN CORP
11 Aug 2022
Senior VP, R&D
Sold, plan not stated
4,840
$1.23M
20.1%
RGEN REPLIGEN CORP
30 Aug 2021
Senior VP, R&D
Sold, plan not stated
4,001
$1.13M
18.7%
RGEN REPLIGEN CORP
10 Jun 2021
Senior VP, R&D
Sold, plan not stated
6,802
$1.29M
24.2%
RGEN REPLIGEN CORP
14 May 2021
Senior VP, R&D
Sold, plan not stated
710
$122.33K
2.8%
RGEN REPLIGEN CORP
10 Mar 2021
Senior VP, R&D
Sold, plan not stated
8,000
$1.52M
24.0%
RGEN REPLIGEN CORP
4 Mar 2021
Senior VP, R&D
Sold, plan not stated
2,075
$398.40K
7.6%
RGEN REPLIGEN CORP
16 Dec 2020
Senior VP, R&D
Sold, plan not stated
435
$80.99K
1.7%
RGEN REPLIGEN CORP
6 Aug 2020
Senior VP, R&D
Sold, plan not stated
5,000
$768.95K
16.1%
RGEN REPLIGEN CORP
15 May 2020
Senior VP, R&D
Sold, plan not stated
435
$61.20K
1.6%
RGEN REPLIGEN CORP
13 May 2020
Senior VP, R&D
Sold, plan not stated
8,000
$1.02M
23.2%
RGEN REPLIGEN CORP
4 Mar 2020
Senior VP, R&D
Sold, plan not stated
2,555
$231.89K
8.8%
RGEN REPLIGEN CORP
3 Mar 2020
Senior VP, R&D
Sold, plan not stated
450
$39.76K
1.5%
RGEN REPLIGEN CORP
26 Feb 2020
Senior VP, R&D
Sold, plan not stated
195
$16.89K
0.7%
RGEN REPLIGEN CORP
5 Mar 2019
Senior VP, R&D
Sold, plan not stated
2,240
$131.11K
10.6%
RGEN REPLIGEN CORP
28 Feb 2019
Senior VP, R&D
Sold, plan not stated
185
$10.94K
1.1%
RGEN REPLIGEN CORP
18 Dec 2018
Senior VP, R&D
Sold, plan not stated
311
$16.93K
2.5%
19 decisions on file.